Elevated interleukin-6 and severe COVID-19: A meta-analysis
J Med Virol
.
2020 Nov;92(11):2283-2285.
doi: 10.1002/jmv.25948.
Epub 2020 Jun 2.
Authors
Muhammad Aziz
1
,
Rawish Fatima
1
,
Ragheb Assaly
2
Affiliations
1
Department of Internal Medicine, University of Toledo Medical Center, Toledo, Ohio.
2
Division of Pulmonary and Critical Care Medicine, University of Toledo Medical Center, Toledo, Ohio.
PMID:
32343429
PMCID:
PMC7267383
DOI:
10.1002/jmv.25948
No abstract available
Publication types
Letter
Comment
MeSH terms
Antibodies, Monoclonal, Humanized
COVID-19*
Humans
Interleukin-6*
SARS-CoV-2
Substances
Antibodies, Monoclonal, Humanized
Interleukin-6
tocilizumab